Related Experiment Video
Updated: Jun 1, 2026
11:13
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Elevated PI3K signaling drives multiple breast cancer subtypes.
Jessica R Adams1, Nathan F Schachter, Jeff C Liu
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, 101 College St., East Tower.
Oncotarget
|June 8, 2011
Summary
Most human breast tumors exhibit mutations activating the phosphatidylinositol 3' kinase (PI3K) pathway, crucial for cell growth. Mouse models of PI3K-activated breast cancer are being developed to guide new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The phosphatidylinositol 3' kinase (PI3K) pathway is frequently dysregulated in human breast tumors.
- This pathway is activated by insulin and growth factors, playing a critical role in cell proliferation and survival.
- Mutations in various genes, including receptors, PI3K components, and phosphatases, lead to elevated PI3K signaling in breast cancer.
Purpose of the Study:
- To investigate the role of PI3K pathway activation in breast cancer development.
- To describe mouse models that mimic human breast tumors with elevated PI3K signaling.
- To explore the potential of these models in guiding the development of novel therapeutics.
Main Methods:
- Development and characterization of mouse models with genetically altered PI3K signaling.
- Analysis of tumor subtypes, prognosis, and therapeutic sensitivity in these models.
- Comparative studies between genetically engineered mouse models and human breast tumors.
Main Results:
- Mouse models successfully replicate elevated PI3K signaling observed in human breast cancers.
- Specific genetic alterations within the PI3K pathway correlate with distinct tumor characteristics.
- Pathway activation is a common feature across major breast cancer subtypes.
Conclusions:
- Elevated PI3K signaling is a hallmark of human breast cancer, driven by diverse genetic mutations.
- Mouse models provide valuable platforms for studying PI3K-driven breast cancer.
- These models can inform the design of targeted therapies for breast cancer patients.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...